Increased Central Venous Pressure Is Associated With Impaired Renal Function and Mortality in a Broad Spectrum of Patients With Cardiovascular Disease

被引:749
作者
Damman, Kevin [1 ]
van Deursen, Vincent M. [1 ]
Navis, Gerjan [2 ]
Voors, Adriaan A. [1 ]
van Veldhuisen, Dirk J. [1 ]
Hillege, Hans L. [1 ,3 ]
机构
[1] Univ Groningen, Dept Cardiol, Groningen, Netherlands
[2] Univ Groningen, Dept Nephrol, Groningen, Netherlands
[3] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands
关键词
renal function; central venous pressure; mortality; prognosis; heart catheterization; CHRONIC KIDNEY-DISEASE; VENTRICULAR DIASTOLIC DYSFUNCTION; DECOMPENSATED HEART-FAILURE; CARDIAC-OUTPUT; RISK; IMPACT; CONGESTION; STRATEGIES; MARKERS; SOUND;
D O I
10.1016/j.jacc.2008.08.080
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives We sought to investigate the relationship between increased central venous pressure (CVP), renal function, and mortality in a broad spectrum of cardiovascular patients. Background The pathophysiology of impaired renal function in cardiovascular disease is multifactorial. The relative importance of increased CVP has not been addressed previously. Methods A total of 2,557 patients who underwent right heart catheterization in the University Medical Center Groningen, the Netherlands, between January 1, 1989, and December 31, 2006, were identified, and their data were extracted from electronic databases. Estimated glomerular filtration rate (eGFR) was assessed with the simplified modification of diet in renal disease formula. Results Mean age was 59 +/- 15 years, and 57% were men. Mean eGFR was 65 +/- 24 ml/min/1.73 m(2), with a cardiac index of 2.9 +/- 0.8 l/min/m(2) and CVP of 5.9 +/- 4.3 mm Hg. We found that CVP was associated with cardiac index (r = -0.259, p < 0.0001) and eGFR (r = -0.147, p < 0.0001). Also, cardiac index was associated with eGFR (r = 0.123, p < 0.0001). In multivariate analysis CVP remained associated with eGFR (r = -0.108, p < 0.0001). In a median follow-up time of 10.7 years, 741 (29%) patients died. We found that CVP was an independent predictor of reduced survival (hazard ratio: 1.03 per mm Hg increase, 95% confidence interval: 1.01 to 1.05, p = 0.0032). Conclusions Increased CVP is associated with impaired renal function and independently related to all-cause mortality in a broad spectrum of patients with cardiovascular disease. (J Am Coll Cardiol 2009; 53: 582-8) (C) 2009 by the American College of Cardiology Foundation
引用
收藏
页码:582 / 588
页数:7
相关论文
共 38 条
[31]   Renal function: The Cinderella of cardiovascular risk profile [J].
Ruilope, LM ;
van Veldhuisen, DJ ;
Ritz, E ;
Luscher, TF .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (07) :1782-1787
[32]   Role of diminished renal function in cardiovascular mortality - Marker or pathogenetic factor? [J].
Schrier, RW .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (01) :1-8
[33]   Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction [J].
Smilde, Tom D. J. ;
van Veldhuisen, Dirk J. ;
Navis, Gerjan ;
Voors, Adriaan A. ;
Hillege, Hans L. .
CIRCULATION, 2006, 114 (15) :1572-1580
[34]   Impaired renal function is associated with markers of endothelial dysfunction and increased inflammatory activity [J].
Stam, F ;
van Guldener, C ;
Schalkwijk, CG ;
ter Wee, PM ;
Donker, AJM ;
Stehouwer, CDA .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 (05) :892-898
[35]  
STOLARCZYK J, 1975, AM J PATHOL, V78, P285
[36]   FACTORS INFLUENCING THE ONE-YEAR MORTALITY OF DILATED CARDIOMYOPATHY [J].
UNVERFERTH, DV ;
MAGORIEN, RD ;
MOESCHBERGER, ML ;
BAKER, PB ;
FETTERS, JK ;
LEIER, CV .
AMERICAN JOURNAL OF CARDIOLOGY, 1984, 54 (01) :147-152
[37]   Levosimendan improves renal function in patients with acute decompensated heart failure: Comparison with dobutamine [J].
Yilmaz, Mehmet Birhan ;
Yalta, Kenan ;
Yontar, Can ;
Karadas, Filiz ;
Erdem, Alim ;
Turgut, Okan Onur ;
Yilmaz, Ahmet ;
Tandogan, Izzet .
CARDIOVASCULAR DRUGS AND THERAPY, 2007, 21 (06) :431-435
[38]   Inflammation and atherosclerosis in end-stage renal disease [J].
Zoccali, C ;
Mallamaci, F ;
Tripepi, G .
BLOOD PURIFICATION, 2003, 21 (01) :29-36